Wilderness medical society consensus guidelines for the prevention and treatment of acute altitude illness

Andrew M. Luks, Scott E. McIntosh, Colin K. Grissom, Paul S. Auerbach, George W Rodway, Robert B. Schoene, Ken Zafren, Peter H. Hackett

Research output: Contribution to journalReview article

188 Scopus citations

Abstract

To provide guidance to clinicians about best practices, the Wilderness Medical Society (WMS) convened an expert panel to develop evidence-based guidelines for the prevention and treatment of acute mountain sickness (AMS), high altitude cerebral edema (HACE), and high altitude pulmonary edema (HAPE). These guidelines present the main prophylactic and therapeutic modalities for each disorder and provide recommendations for their roles in disease management. Recommendations are graded based on the quality of supporting evidence and balance between the benefits and risks/burdens according to criteria put forth by the American College of Chest Physicians. The guidelines also provide suggested approaches to the prevention and management of each disorder that incorporate these recommendations.

Original languageEnglish (US)
Pages (from-to)146-155
Number of pages10
JournalWilderness and Environmental Medicine
Volume21
Issue number2
DOIs
StatePublished - Jun 2010
Externally publishedYes

    Fingerprint

Keywords

  • Acetazolamide
  • Acute mountain sickness
  • Dexamethasone
  • High altitude
  • High altitude cerebral edema
  • High altitude pulmonary edema
  • Nifedipine
  • Salmeterol
  • Sildenafil
  • Tadalafil

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Emergency Medicine
  • Medicine(all)

Cite this

Luks, A. M., McIntosh, S. E., Grissom, C. K., Auerbach, P. S., Rodway, G. W., Schoene, R. B., Zafren, K., & Hackett, P. H. (2010). Wilderness medical society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness and Environmental Medicine, 21(2), 146-155. https://doi.org/10.1016/j.wem.2010.03.002